SNCA and Parkinson disease: Together, these miRNAs target complementary PD-pathway mechanisms—enhancing autophagic clearance of aggregated α-synuclein, suppressing apoptosis, and preventing neuroinflammation—to preserve dopaminergic neuron integrity and slow disease progression [109].